Determination and Control of Volatilized 131I Released in the Preparation of 131I Tositumomab Dosages for Radioimmunotherapy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American Pharmacists Association 2003-09, Vol.43 (5), p.646-648
Hauptverfasser:	Augustine, Samuel C., Colcher, David M., Rutar, Frank J., Norenberg, Jeffrey P., Vang, Kao
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal - pharmacokinetics Antibodies, Monoclonal - therapeutic use Antineoplastic Agents - pharmacokinetics Antineoplastic Agents - therapeutic use Drug Compounding - methods Half-Life Humans Lymphoma, Non-Hodgkin - radiotherapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	648
container_issue	5
container_start_page	646
container_title	Journal of the American Pharmacists Association
container_volume	43
creator	Augustine, Samuel C. Colcher, David M. Rutar, Frank J. Norenberg, Jeffrey P. Vang, Kao
description
doi_str_mv	10.1331/154434503322452319
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71394953</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1544319115319233</els_id><sourcerecordid>71394953</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1500-d13268aa04b0b6b650aee969ac1431f6805fce9bd32e11120b1c7898bcbfa3e43</originalsourceid><addsrcrecordid>eNp9kM1LxDAQxYMofv8DHiQnb6uZJM024EXWTxCURb2WJJ1qpG3WpBVW_OPtuiseBE8z8_i9B_MIOQB2DELACWRSCpkxITiXGReg18j2Qhwt1PWfHTRskZ2UXhnjY6XzTbIFUnE1VmybfJ5jh7Hxrel8aKlpSzoJbRdDTUNFn0I96LX_wJKCgBs6xRpNGi7f0u4F6X3EmYlL78B_Mw8h-a5vQmMsPQ_JPGOiVYh0akoffNP0bRis0czme2SjMnXC_dXcJY-XFw-T69Ht3dXN5Ox25CBjbFSC4Co3hknLrLIqYwZRK20cSAGVyllWOdS2FBwBgDMLbpzr3DpbGYFS7JKjZe4shrceU1c0Pjmsa9Ni6FMxBqGlzsQA8iXoYkgpYlXMom9MnBfAikXnxd_OB9PhKr23DZa_llXJA3C6BHD48d1jLJLz2DosfUTXFWXw_-V_ATq_jy0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71394953</pqid></control><display><type>article</type><title>Determination and Control of Volatilized 131I Released in the Preparation of 131I Tositumomab Dosages for Radioimmunotherapy</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Augustine, Samuel C. ; Colcher, David M. ; Rutar, Frank J. ; Norenberg, Jeffrey P. ; Vang, Kao</creator><creatorcontrib>Augustine, Samuel C. ; Colcher, David M. ; Rutar, Frank J. ; Norenberg, Jeffrey P. ; Vang, Kao</creatorcontrib><identifier>ISSN: 1544-3191</identifier><identifier>EISSN: 1544-3450</identifier><identifier>DOI: 10.1331/154434503322452319</identifier><identifier>PMID: 14626760</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Antibodies, Monoclonal - pharmacokinetics ; Antibodies, Monoclonal - therapeutic use ; Antineoplastic Agents - pharmacokinetics ; Antineoplastic Agents - therapeutic use ; Drug Compounding - methods ; Half-Life ; Humans ; Lymphoma, Non-Hodgkin - radiotherapy</subject><ispartof>Journal of the American Pharmacists Association, 2003-09, Vol.43 (5), p.646-648</ispartof><rights>2003 American Pharmacists Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1500-d13268aa04b0b6b650aee969ac1431f6805fce9bd32e11120b1c7898bcbfa3e43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14626760$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Augustine, Samuel C.</creatorcontrib><creatorcontrib>Colcher, David M.</creatorcontrib><creatorcontrib>Rutar, Frank J.</creatorcontrib><creatorcontrib>Norenberg, Jeffrey P.</creatorcontrib><creatorcontrib>Vang, Kao</creatorcontrib><title>Determination and Control of Volatilized 131I Released in the Preparation of 131I Tositumomab Dosages for Radioimmunotherapy</title><title>Journal of the American Pharmacists Association</title><addtitle>J Am Pharm Assoc (2003)</addtitle><subject>Antibodies, Monoclonal - pharmacokinetics</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antineoplastic Agents - pharmacokinetics</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Drug Compounding - methods</subject><subject>Half-Life</subject><subject>Humans</subject><subject>Lymphoma, Non-Hodgkin - radiotherapy</subject><issn>1544-3191</issn><issn>1544-3450</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1LxDAQxYMofv8DHiQnb6uZJM024EXWTxCURb2WJJ1qpG3WpBVW_OPtuiseBE8z8_i9B_MIOQB2DELACWRSCpkxITiXGReg18j2Qhwt1PWfHTRskZ2UXhnjY6XzTbIFUnE1VmybfJ5jh7Hxrel8aKlpSzoJbRdDTUNFn0I96LX_wJKCgBs6xRpNGi7f0u4F6X3EmYlL78B_Mw8h-a5vQmMsPQ_JPGOiVYh0akoffNP0bRis0czme2SjMnXC_dXcJY-XFw-T69Ht3dXN5Ox25CBjbFSC4Co3hknLrLIqYwZRK20cSAGVyllWOdS2FBwBgDMLbpzr3DpbGYFS7JKjZe4shrceU1c0Pjmsa9Ni6FMxBqGlzsQA8iXoYkgpYlXMom9MnBfAikXnxd_OB9PhKr23DZa_llXJA3C6BHD48d1jLJLz2DosfUTXFWXw_-V_ATq_jy0</recordid><startdate>200309</startdate><enddate>200309</enddate><creator>Augustine, Samuel C.</creator><creator>Colcher, David M.</creator><creator>Rutar, Frank J.</creator><creator>Norenberg, Jeffrey P.</creator><creator>Vang, Kao</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200309</creationdate><title>Determination and Control of Volatilized 131I Released in the Preparation of 131I Tositumomab Dosages for Radioimmunotherapy</title><author>Augustine, Samuel C. ; Colcher, David M. ; Rutar, Frank J. ; Norenberg, Jeffrey P. ; Vang, Kao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1500-d13268aa04b0b6b650aee969ac1431f6805fce9bd32e11120b1c7898bcbfa3e43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Antibodies, Monoclonal - pharmacokinetics</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antineoplastic Agents - pharmacokinetics</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Drug Compounding - methods</topic><topic>Half-Life</topic><topic>Humans</topic><topic>Lymphoma, Non-Hodgkin - radiotherapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Augustine, Samuel C.</creatorcontrib><creatorcontrib>Colcher, David M.</creatorcontrib><creatorcontrib>Rutar, Frank J.</creatorcontrib><creatorcontrib>Norenberg, Jeffrey P.</creatorcontrib><creatorcontrib>Vang, Kao</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Pharmacists Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Augustine, Samuel C.</au><au>Colcher, David M.</au><au>Rutar, Frank J.</au><au>Norenberg, Jeffrey P.</au><au>Vang, Kao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Determination and Control of Volatilized 131I Released in the Preparation of 131I Tositumomab Dosages for Radioimmunotherapy</atitle><jtitle>Journal of the American Pharmacists Association</jtitle><addtitle>J Am Pharm Assoc (2003)</addtitle><date>2003-09</date><risdate>2003</risdate><volume>43</volume><issue>5</issue><spage>646</spage><epage>648</epage><pages>646-648</pages><issn>1544-3191</issn><eissn>1544-3450</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>14626760</pmid><doi>10.1331/154434503322452319</doi><tpages>3</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 1544-3191
ispartof	Journal of the American Pharmacists Association, 2003-09, Vol.43 (5), p.646-648
issn	1544-3191 1544-3450
language	eng
recordid	cdi_proquest_miscellaneous_71394953
source	MEDLINE; Alma/SFX Local Collection
subjects	Antibodies, Monoclonal - pharmacokinetics Antibodies, Monoclonal - therapeutic use Antineoplastic Agents - pharmacokinetics Antineoplastic Agents - therapeutic use Drug Compounding - methods Half-Life Humans Lymphoma, Non-Hodgkin - radiotherapy
title	Determination and Control of Volatilized 131I Released in the Preparation of 131I Tositumomab Dosages for Radioimmunotherapy
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T06%3A16%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Determination%20and%20Control%20of%20Volatilized%20131I%20Released%20in%20the%20Preparation%20of%20131I%20Tositumomab%20Dosages%20for%20Radioimmunotherapy&rft.jtitle=Journal%20of%20the%20American%20Pharmacists%20Association&rft.au=Augustine,%20Samuel%20C.&rft.date=2003-09&rft.volume=43&rft.issue=5&rft.spage=646&rft.epage=648&rft.pages=646-648&rft.issn=1544-3191&rft.eissn=1544-3450&rft_id=info:doi/10.1331/154434503322452319&rft_dat=%3Cproquest_cross%3E71394953%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71394953&rft_id=info:pmid/14626760&rft_els_id=S1544319115319233&rfr_iscdi=true